Biopharma · FDA Approvals · Stock

BHC Bausch Health

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Produ…

Catalyst calendar

Dated catalysts for BHC, including recently decided ones.

October 2026
~
Oct 2026
~ Oct 2026
BHCBausch Health

Bausch Health/Salix to Present Cirrhosis Clinical Pathway Pilot Study at ACG 2026

Conference presentationCompany press releaseMonth only

Recent first-hand events

Every first-hand event for BHC, newest first.

Instant stream — events appear as soon as they are filed.
Decision-gradeMaterialNotableMinor
Oct 12, 2026
08:00 PM
BHCBausch Health

Bausch Health/Salix to Present Cirrhosis Clinical Pathway Pilot Study at ACG 2026

A six-month pilot study of a standardized cirrhosis clinical pathway in five community gastroenterology practices showed modest improvements in adherence to five guideline-based performance indicators. The results will be presented as a poster at the American College of Gastroenterology Annual Scientific Meeting taking place October 9-14, 2026.

Conference presentationCompany press release

Peers by market cap

Companies in the same sector closest to BHC in market value.